GB9812941D0 - Method of treatment - Google Patents

Method of treatment

Info

Publication number
GB9812941D0
GB9812941D0 GBGB9812941.4A GB9812941A GB9812941D0 GB 9812941 D0 GB9812941 D0 GB 9812941D0 GB 9812941 A GB9812941 A GB 9812941A GB 9812941 D0 GB9812941 D0 GB 9812941D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9812941.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9812941.4A priority Critical patent/GB9812941D0/en
Publication of GB9812941D0 publication Critical patent/GB9812941D0/en
Priority to NZ508532A priority patent/NZ508532A/en
Priority to JP2000554371A priority patent/JP2002518330A/ja
Priority to US09/719,378 priority patent/US6300343B1/en
Priority to BR9911150-0A priority patent/BR9911150A/pt
Priority to PCT/US1999/013623 priority patent/WO1999065491A1/en
Priority to EP99930327A priority patent/EP1087766A4/en
Priority to HU0102507A priority patent/HUP0102507A3/hu
Priority to APAP/P/2000/002002A priority patent/AP2000002002A0/en
Priority to CZ20004698A priority patent/CZ20004698A3/cs
Priority to IL13994399A priority patent/IL139943A0/xx
Priority to CA002335236A priority patent/CA2335236A1/en
Priority to SK1919-2000A priority patent/SK19192000A3/sk
Priority to EA200100041A priority patent/EA003584B1/ru
Priority to KR1020007014240A priority patent/KR20010052895A/ko
Priority to CN99807465A priority patent/CN1305379A/zh
Priority to AU46885/99A priority patent/AU740749B2/en
Priority to PL99345261A priority patent/PL345261A1/xx
Priority to ZA200007396A priority patent/ZA200007396B/xx
Priority to NO20006383A priority patent/NO20006383L/no
Priority to BG105127A priority patent/BG105127A/xx
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB9812941.4A 1998-06-16 1998-06-16 Method of treatment Ceased GB9812941D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GBGB9812941.4A GB9812941D0 (en) 1998-06-16 1998-06-16 Method of treatment
PL99345261A PL345261A1 (en) 1998-06-16 1999-06-16 Method of treatment
IL13994399A IL139943A0 (en) 1998-06-16 1999-06-16 Method of treatment
SK1919-2000A SK19192000A3 (sk) 1998-06-16 1999-06-16 Použitie paroxetínu alebo jeho farmaceuticky prijateľnej soli alebo solvátu na podporu odvykania od fajčenia alebo na zníženie alebo prevenciu relapsu fajčenia
US09/719,378 US6300343B1 (en) 1998-06-16 1999-06-16 Method of treatment
BR9911150-0A BR9911150A (pt) 1998-06-16 1999-06-16 Método de tratamento
PCT/US1999/013623 WO1999065491A1 (en) 1998-06-16 1999-06-16 Method of treatment
EP99930327A EP1087766A4 (en) 1998-06-16 1999-06-16 TREATMENT METHOD
HU0102507A HUP0102507A3 (en) 1998-06-16 1999-06-16 Use of paroxetine in manufacture of a medicament for use in promoting smoking cessation or reduction or preventing smoking
APAP/P/2000/002002A AP2000002002A0 (en) 1998-06-16 1999-06-16 Method of treatment.
CZ20004698A CZ20004698A3 (cs) 1998-06-16 1999-06-16 Lék pro podporu skončení nebo omezení kouření nebo prevence recidivy kouření
NZ508532A NZ508532A (en) 1998-06-16 1999-06-16 Method for promoting smoking cessation or reduction or preventing relapse smoking
CA002335236A CA2335236A1 (en) 1998-06-16 1999-06-16 Method of treatment
JP2000554371A JP2002518330A (ja) 1998-06-16 1999-06-16 処置方法
EA200100041A EA003584B1 (ru) 1998-06-16 1999-06-16 Способ стимуляции отказа от курения или его снижения или предупреждения возобновления курения и применение пароксетина или его фармацевтически приемлемых солей или сольватов для получения лекарственного средства
KR1020007014240A KR20010052895A (ko) 1998-06-16 1999-06-16 치료 방법
CN99807465A CN1305379A (zh) 1998-06-16 1999-06-16 治疗方法
AU46885/99A AU740749B2 (en) 1998-06-16 1999-06-16 Method of treatment
ZA200007396A ZA200007396B (en) 1998-06-16 2000-12-12 Method of treatment.
NO20006383A NO20006383L (no) 1998-06-16 2000-12-14 Fremgangsmåte for behandling
BG105127A BG105127A (en) 1998-06-16 2001-01-08 Method for treament of nicotine addiction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9812941.4A GB9812941D0 (en) 1998-06-16 1998-06-16 Method of treatment

Publications (1)

Publication Number Publication Date
GB9812941D0 true GB9812941D0 (en) 1998-08-12

Family

ID=10833832

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9812941.4A Ceased GB9812941D0 (en) 1998-06-16 1998-06-16 Method of treatment

Country Status (20)

Country Link
EP (1) EP1087766A4 (ru)
JP (1) JP2002518330A (ru)
KR (1) KR20010052895A (ru)
CN (1) CN1305379A (ru)
AP (1) AP2000002002A0 (ru)
AU (1) AU740749B2 (ru)
BG (1) BG105127A (ru)
BR (1) BR9911150A (ru)
CA (1) CA2335236A1 (ru)
CZ (1) CZ20004698A3 (ru)
EA (1) EA003584B1 (ru)
GB (1) GB9812941D0 (ru)
HU (1) HUP0102507A3 (ru)
IL (1) IL139943A0 (ru)
NO (1) NO20006383L (ru)
NZ (1) NZ508532A (ru)
PL (1) PL345261A1 (ru)
SK (1) SK19192000A3 (ru)
WO (1) WO1999065491A1 (ru)
ZA (1) ZA200007396B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2418038A1 (en) * 2000-08-28 2002-03-07 Synthon B.V. Paroxetine compositions and processes for making the same
EP1575478A2 (en) 2001-12-28 2005-09-21 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
WO2006023347A1 (en) * 2004-08-20 2006-03-02 Alpharma, Inc. Paroxetine formulations
FR2926221A1 (fr) * 2008-01-14 2009-07-17 Tassin Thomas Compositions permettant la reproduction artificielle des conditions pharmacologiques de la dependance aux drogues addictives telles que opiaces, psychostimulants, tabac et alcool, par la combinaison de nicotine et d'un ligand.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
WO1992009281A2 (en) * 1990-11-24 1992-06-11 Beecham Group Plc Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method

Also Published As

Publication number Publication date
EA003584B1 (ru) 2003-06-26
AU740749B2 (en) 2001-11-15
PL345261A1 (en) 2001-12-03
ZA200007396B (en) 2002-02-27
SK19192000A3 (sk) 2001-05-10
EP1087766A1 (en) 2001-04-04
CN1305379A (zh) 2001-07-25
HUP0102507A3 (en) 2003-12-29
JP2002518330A (ja) 2002-06-25
AU4688599A (en) 2000-01-05
AP2000002002A0 (en) 2000-12-31
NZ508532A (en) 2003-08-29
IL139943A0 (en) 2002-02-10
KR20010052895A (ko) 2001-06-25
BR9911150A (pt) 2001-03-06
NO20006383D0 (no) 2000-12-14
CZ20004698A3 (cs) 2002-02-13
EP1087766A4 (en) 2001-11-21
CA2335236A1 (en) 1999-12-23
BG105127A (en) 2001-11-30
EA200100041A1 (ru) 2001-06-25
NO20006383L (no) 2000-12-14
HUP0102507A2 (hu) 2002-05-29
WO1999065491A1 (en) 1999-12-23

Similar Documents

Publication Publication Date Title
GB9824436D0 (en) Methods of treatment
HU0001471D0 (en) New method of treatment
GB9715295D0 (en) Novel method of treatment
GB9712866D0 (en) Novel method of treatment
GB9707693D0 (en) Novel method of treatment
GB9715298D0 (en) Novel method of treatment
PL341667A1 (en) Method of treating cooped
GB9715306D0 (en) Novel method of treatment
PL345261A1 (en) Method of treatment
PL349421A1 (en) Novel method of treatment
GB9822681D0 (en) Method of treatment
GB9808479D0 (en) Method of treatment
GB9822459D0 (en) Method of treatment
GB9811961D0 (en) Method of treatment
GB9818776D0 (en) Method of treatment
EG24158A (en) Novel method of treatment
GB9824790D0 (en) Novel method of treatment
GB9824871D0 (en) Novel method of treatment
GB9824789D0 (en) Novel method of treatment
SI1135128T1 (sl) Nov postopek zdravljenja
GB9822458D0 (en) Methods of treatment
GB9800707D0 (en) Methods of treatment
GB9824208D0 (en) Methods of treatment
GB9717399D0 (en) Method of treatment
GB9724289D0 (en) Method of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)